Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Aptar and Sonmol Partner to Develop Digital Platform for Respiratory-Related Therapies
Wednesday, April 22, 2020AptarGroup Inc a global leader in consumer dispensing active packaging and drug delivery solutions and services and Sonmol a leading Chinese digital respiratory therapeutics company have announced a collaboration for developing a digital therapies an...
Amblyotech, A Digital Therapeutics Company, Announces It Has Been Acquired by Novartis
Tuesday, April 21, 2020Amblyotech a USbased digital therapeutics company announced that it has completed the sale of all of its outstanding shares to Novartis pursuant to a Share Purchase Agreement entered into between each shareholder of Amblyotech and Novartis After the...
Anixa Biosciences and OntoChem Announce Collaboration to Develop Novel COVID-19 Therapeutics
Tuesday, April 21, 2020Anixa Biosciences Inc a biotechnology company focused on the treatment prevention and diagnosis of cancer and infectious diseases today announced that it has entered into a strategic collaboration with OntoChem GmbH to discover and develop antiviral...
Fosun Pharma Receives FDA Emergency Use Authorization (EUA) For Its COVID-19 RT-PCR Detection Kit
Monday, April 20, 2020US Food and Drug Administration FDA Shanghai Fosun Pharmaceutical Group Co Ltd has received emergency use authorization EUA from FDA for its COVID RTPCR detection kitThe testing kit which was selfdeveloped by Fosun Long March a whollyowned subsidiary...
Oncolytics Biotech® Updates Clinical Development and Operations Activities During the COVID-19 Pandemic
Saturday, April 18, 2020Oncolytics Biotech Inc currently developing pelareorep an intravenously delivered immunooncolytic virus today provided an update on the potential impact of COVID on the Companys clinical and business operations
Chi-Med Announces Surufatinib Granted U.S. FDA Fast Track Designations for the Treatment of Both Pancreatic and Non-Pancreatic Neuroendocrine Tumors
Saturday, April 18, 2020Hutchison China MediTech Limited announces that the US Food and Drug Administration FDA has granted two Fast Track Designations for the development of surufatinib for the treatment of both advanced and progressive pancreatic neuroendocrine tumors NE...
Soligenix Announces Exclusive Licensing Agreement for Novel Vaccine Adjuvant from BTG Specialty Pharmaceuticals
Friday, April 17, 2020Soligenix Inc a latestage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need announced today that it has executed an agreement for the exclusive worldwide license o...
LegoChem Biosciences and Iksuda Enter into a Multi-Target Research Collaboration and License Agreement for the Development of Antibody-Drug Conjugates
Friday, April 17, 2020LegoChem Biosciences Inc based in Daejeon South Korea announced that it has entered a research collaboration and license agreement with Iksuda Therapeutics Iksuda for the development of antibodydrug conjugates in oncology
ImmunoPrecise Announces Agreement with Janssen
Thursday, April 16, 2020IMMUNOPRECISE ANTIBODIES LTD a global leader in therapeutic antibody discovery and development announced that it through its subsidiary Talem Therapeutics has entered into a research license agreement the Agreement with Janssen Research Development...
TScan Announces Collaboration with Novartis on the Discovery and Development of Novel T Cell Receptor Therapies for the Treatment of Solid Tumors
Thursday, April 16, 2020TScan Therapeutics a biopharmaceutical company focused on the development of T cell receptor TCR therapies which reprogram a patients own T cells to recognize shared cancer targets today announced an agreement with Novartis to discover and develop no...
